Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Astrazeneca Ord Shs AZNCF

Healthcare
AstraZeneca PLC is a science-led biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza... see more

Recent & Breaking News (OTCPK:AZNCF)

Medtronic Paying $43 Billion for Covidien, Moving HQ to Ireland

Equities.com June 16, 2014

How the Lack of R&D at Big Pharma Is Boosting Small Biotechs

Equities.com June 14, 2014

Why is Biotech Stock Nektar Therapeutics Surging Higher?

Equities.com June 13, 2014

Prescription for Profit: Pharma-Biotech Industry Continues Mega-Billion Dollar Merger & Acquisition Binge, an Industrial Info News Alert

Marketwired June 11, 2014

Looking at the Latest in Immunotherapies

Equities.com June 5, 2014

Cigna Customers Prescribed CRESTOR May Lower Their Bad Cholesterol with Reduced Out-of-Pocket Costs

Business Wire June 2, 2014

Pfizer (PFE) nixes takeover bid for rival drugmaker AstraZeneca (AZN) after $119B offer rejected

Canadian Press May 26, 2014

Pfizer (PFE) drops takeover plans for AstraZeneca (AZN)

Canadian Press May 26, 2014

Cannabis Therapy Secures Lease & Crop Management Services

Accesswire May 21, 2014

AstraZeneca (AZN) board passes on Pfizer's (PFE) $119 bil bid, shares dump

Canadian Press May 19, 2014

Exosomes Common Link in Cancer Drug Development

Accesswire May 15, 2014

Ardelyx Receives $25 Million Milestone From AstraZeneca For Commencement Of Phase 2b Clinical Trial Of Tenapanor

PR Newswire May 15, 2014

SumTotal Webinars Focus on Optimizing Workforce to Meet Compliance Requirements

Business Wire May 14, 2014

Fallon Health Achieves Success Using SumTotal Talent Expansion(TM) for Employee Engagement, Regulatory Compliance

Business Wire May 6, 2014

FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia

PR Newswire May 6, 2014

Pfizer (PFE) Q1 profits drop 15% on generic competition

Canadian Press May 5, 2014

AstraZeneca's MedImmune Specialty Care to Present Eleven Abstracts on Influenza, RSV at Upcoming Annual Pediatric Academic Societies Meeting

Business Wire May 3, 2014

AstraZeneca (AZN) passes on Pfizer's (PFE) $106 bil bid

Canadian Press May 2, 2014

Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate, an Industrial Info News Alert

Marketwired April 30, 2014

AstraZeneca (AZN) pops 15% after Pfizer (PFE) makes $100 bil takeover bid

Canadian Press April 28, 2014